skip to main
|
skip to sidebar
Blog Archives: Nov 2004 - present
Special items: Ovarian Cancer and Us blog best viewed in Firefox
Clinical Oncology News
A U.K. study that evaluated the cost-effectiveness of risk-reducing
salpingo-oophorectomy (RRSO), the most successful intervention to
prevent ovarian cancer, has emphasized the importance of hormone
replacement therapy (HRT) in premenopausal women after surgery.
Original article (abstract): Specifying
the ovarian cancer risk threshold of ‘premenopausal risk-reducing
salpingo-oophorectomy’ for ovarian cancer prevention:
a cost-effectiveness analysis J Med Genet 2016;53:9 591-599
Outcomes included in the analyses were OC, breast cancer (BC) and
additional deaths from coronary heart disease. Total costs and effects
were estimated in terms of quality-adjusted life-years (QALYs);
incidence of OC and BC; as well as incremental cost-effectiveness ratio
(ICER).
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.